Agafonova Nataliya has filed a report indicating a change in beneficial ownership of securities. This filing, dated October 5, 2026, is significant as it may suggest shifts in management or strategic direction within the company.
Agafonova Nataliya is categorized under the entity type 'other' and does not have a specific SIC description or ticker symbol associated with it. The recent filings include a series of Form 4 submissions, with the latest being on October 5, 2026. This indicates ongoing activity related to ownership changes.
The filing states that the report period was from October 1, 2026. However, specific details regarding the nature of the ownership change were not disclosed in the filing. The filing does not provide further context or implications for the company or its operations.
This development may affect stakeholders, including potential investors and analysts who track ownership changes for insights into company strategies. Transparency in ownership is essential in the pharmaceutical preparations sector, as it can influence investor confidence and market perceptions.
Details were not available in the SEC filing regarding what happens next following this report. Stakeholders may want to keep an eye on future filings for additional information.
Company and Reporting Details
Agafonova Nataliya is associated with Longeveron Inc., which is categorized under the SIC code 2834, indicating its primary business in pharmaceutical preparations. The company is incorporated in Delaware and has a fiscal year ending on December 31.
The filing indicates that the CIK (Central Index Key) for Longeveron Inc. is 0001721484, which can be used for further research on the company's filings and financial information.
Contact Information
The business address for both Agafonova Nataliya and Longeveron Inc. is listed as 1951 NW 7th Avenue, Suite 520, Miami, FL 33136. A contact number is also provided: 305-302-7158, which may be useful for stakeholders seeking direct communication.
Missing Information
While the filing provides essential details regarding the ownership change, it does not specify the exact nature of the securities involved, the number of shares affected, or the reasons behind the ownership change. Additionally, there is no information on any potential implications for the company's future operations or strategic plans.